Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevazin and vitamin B1 for chemotherapy-induced neuropathy
IRCT20230722058878N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of thiamine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Qazvin University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
thiamine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20230722058878N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230722058878N1.